BAX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
3.0B
+9.6%
2.7B
-9.2%
3.0B
+4.9%
2.8B
+0.9%
2.8B
Cost of Revenue
1.9B
+6.5%
1.8B
-24.5%
2.4B
+27.2%
1.9B
+3.6%
1.8B
Gross Profit
1.0B
+15.8%
891.0M
+54.4%
577.0M
-39.3%
950.0M
-4.1%
991.0M
Operating Expenses
815.0M
-1.2%
825.0M
-39.9%
1.4B
+66.1%
826.0M
+3.3%
800.0M
R&D
129.0M
-7.2%
139.0M
+10.3%
126.0M
+6.8%
118.0M
-11.9%
134.0M
SG&A
735.0M
+1.0%
728.0M
-4.3%
761.0M
+7.5%
708.0M
-1.4%
718.0M
Operating Income
217.0M
+228.8%
66.0M
+108.3%
-795000000
-741.1%
124.0M
-35.1%
191.0M
EBITDA
456.0M
+50.5%
303.0M
+532.9%
-70000000
-119.4%
361.0M
-19.4%
448.0M
Net Income
126.0M
+940.0%
-15000000
+98.6%
-1071000000
-2228.3%
-46000000
-150.5%
91.0M
EPS (Basic)
$0.24
+900.0%
$-0.03
+98.6%
$-2.09
-2222.2%
$-0.09
-150.0%
$0.18
EPS (Diluted)
$0.24
+900.0%
$-0.03
+98.6%
$-2.10
-2233.3%
$-0.09
-150.0%
$0.18
Shares (Diluted)
518.0M
+0.6%
515.0M
+1.0%
510.0M
-0.8%
514.0M
+0.0%
514.0M
Baxter International (BAX) โ€” Financials